CrownBio expands immuno-oncology offerings
Crown Bioscience has expanded its immuno-oncology platform at its facilities in Europe, the US, and Asia to include immunophenotyping analysis.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs